EU regulator reviewing Moderna COVID shot for auto-immune blood condition

1 minute read

The exterior of the European Medicines Agency is seen in Amsterdam, Netherlands, December 18, 2020. REUTERS/Piroschka van de Wouw

Register now for FREE unlimited access to Reuters.com

July 14 (Reuters) - Europe's drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc's (MRNA.O) COVID-19 shot, but no "clear causal relationship" could be established between the two.

The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna's vaccine, Spikevax.

Register now for FREE unlimited access to Reuters.com
Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich

Our Standards: The Thomson Reuters Trust Principles.